(Q42487660)

1 November 2017

title

Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome (English)

1 reference

1 November 2017

main subject

metastatic breast cancer

1 reference

R Yerushalmi

1

1 reference

1 November 2017

S Tyldesley

2

1 reference

1 November 2017

H Kennecke

3

1 reference

1 November 2017

C Speers

4

1 reference

1 November 2017

R Woods

5

1 reference

1 November 2017

B Knight

6

1 reference

1 November 2017

K A Gelmon

7

1 reference

1 November 2017

publication date

4 May 2011

1 reference

1 November 2017

1 reference

1 November 2017

volume

23

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

338-345

1 reference

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR154

Role of tumour markers in monitoring epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR154

Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR154

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR154

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR154

Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR154

Shedding light on mammary stem cells and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR154

Serum tumour markers: how to order and interpret them

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR154

Target-specific cytotoxic activity of recombinant immunotoxin scFv(MUC1)-ETA on breast carcinoma cells and primary breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR154

Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR154

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDR154

1 reference

1 November 2017

1 reference